Every European biotech and pharma round Sesamers has verified, most recent first. 46 rounds carry the tag, with four fresh rounds in the past two weeks alone – the most active recent pace of any vertical built so far.
| Big Picture Bio | €1.75M | Pre-seed | 18 Sep 2026 | London, UK | Kadmos Capital, Exceptional Ventures |
| Eterna Regeneratives | $3.5M-$4M | Seed | 16 Sep 2026 | London, UK | Hoxton Ventures, The Venture Collective |
| CONNECTA Therapeutics | €3.1M | Series A | 10 Sep 2026 | Barcelona, ES | Clave Capital |
| sci2sci | €1.2M | Pre-seed | 8 Sep 2026 | Berlin, DE | Heliad, IBB Ventures |
Clear the filters, or widen the scope.
Try again in a few minutes.
Four fresh rounds shown of 46 tracked, all pre-seed to Series A – this desk skews earlier-stage than fintech or wealthtech. Big Picture Bio also raised an €820K Innovate UK grant alongside its pre-seed, shown separately in the database but reflecting one funding event. Eterna Regeneratives’ seed is recorded in USD by the company (“USD 4 million”) though the round record shows €3.5M – the discrepancy likely reflects currency conversion at different dates and is flagged here rather than silently resolved.